Cavadis
Latest round
- Series A
Last raised
- May 2009
Total raised
- Undisclosed
Investors
- 3
About Cavadis
V. is a biomedical company active in the field of atherosclerosis and the identification of patients with high cardiovascular risks. Heico Breek, formerly VP at Aventis Pharma now chairs the company as CEO. The company identified novel biomarkers useful in predicting cardiovascular events such as heart attacks and strokes. The company has developed biomarkers in plasma and atherosclerotic vessel wall tissue.V. Insufficiency of the traditional risk factors to accurately predict cardiovascular events led the company to develop immunoassays based on novel biomarkers. Such biomarkers distinguish patients as high-risk or low-risk and accordingly enable the company to develop stratification tools to provide personalized treatment and treat-to-target medication schemes. The company’s products include Cavadis Pipeline used for developing prognostic tests for identifying myocardial infarction (MI) and peripheral arterial diseases (PAD). A panel of biomarkers was being validated in the primary and secondary prevention cohorts to develop CAVARISK assays. The company subsequently developed CAVARISK CAD which a blood-based prognostic assay to identify patients at risk for coronary artery disease (CAD). The company has also identified a panel of differentially expressed exosomal biomarkers that are used in drug development for patient stratification and as surrogate endpoints in clinical trials. In the future, the company aims to expand research into the development of novel biomarkers for predicting and preventing secondary cardiovascular events.
Who invested in Cavadis
3 investors across 1 round
See all investors in Cavadis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 26, 2009
Amount
Undisclosed
Investors
Questions about Cavadis
Who invested in Cavadis?
Cavadis has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cavadis raised?
Cavadis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cavadis last raise money?
Cavadis's most recent round on record is a Series A, in May 2009.
What does Cavadis do?
Cavadis is a biotechnology company.
Where is Cavadis headquartered?
Cavadis is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like Cavadis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Cavadis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cavadis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.